IL-27, targeting antigen-presenting cells, promotes Th17 differentiation and colitis in mice. - Wikidata - awgldk - TriplyDB

IL-27, targeting antigen-presenting cells, promotes Th17 differentiation and colitis in mice.

IL-27, targeting antigen-presenting cells, promotes Th17 differentiation and colitis in mice.

http://www.wikidata.org/entity/Q38795605

about

Th1/Th2 Balance and Th17/Treg-Mediated Immunity in relation to Murine Resistance to Dextran Sulfate-Induced Colitis IL-27-induced modulation of autoimmunity and its therapeutic potential.Cellular factors targeting APCs to modulate adaptive T cell immunity.Cutting edge: IFN-γR signaling in non-T cell targets regulates T cell-mediated intestinal inflammation through multiple mechanisms.The role of the mediators of inflammation in cancer development.Interleukin-27 as a Novel Therapy for Inflammatory Bowel Disease: A Critical Review of the Literature.Recent Advances: The Imbalance of Cytokines in the Pathogenesis of Inflammatory Bowel Disease.Regulation and Immune Function of IL-27.TIR-domain-containing adapter-inducing interferon-β (TRIF) regulates Th17-mediated intestinal immunopathology in colitis.Interleukin-27 Is a Potential Rescue Therapy for Acute Severe Colitis Through Interleukin-10-Dependent, T-Cell-Independent Attenuation of Colonic Mucosal Innate Immune Responses.Interleukin 27 is up-regulated in patients with active inflammatory bowel disease

P2860

Q33726361-1C8CC76A-E812-483F-B7CD-6615E67AA973 Q34488727-5B35AD15-7F63-4B46-AC3B-93697C42021C Q38240155-FD8F2E0D-5F24-4038-B184-23DDCF1CBD64 Q38260780-D12B86F9-A1F6-4611-AB04-B31AC05CC392 Q38367696-479241DF-2C12-4F33-924F-3681E6824DDD Q38848936-C6D37EFC-29F7-40A0-B9F1-28E7CE026EC0 Q39249504-FC2C3C41-EAA0-4278-9E34-3318DB71BFD1 Q40508641-BDDF6876-C53E-4B80-8CE9-C681FD9FA0A2 Q42182478-441852FB-646F-4AEA-8994-3ED45E695B79 Q47903966-4EB89DFD-CFB6-4F70-AECE-A4559FEC33B9 Q57735511-AA41B87E-64CE-47D1-AAEA-CC8B36E4CE17

P2860

IL-27, targeting antigen-presenting cells, promotes Th17 differentiation and colitis in mice.

http://www.wikidata.org/entity/Q38795605

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

IL-27, targeting antigen-prese ...... entiation and colitis in mice.

@en

type

label

IL-27, targeting antigen-prese ...... entiation and colitis in mice.

@en

prefLabel

IL-27, targeting antigen-prese ...... entiation and colitis in mice.

@en

P1433

Q38795605-95554EC0-CEE7-430F-995A-71FBEEF39D16

P1476

Q38795605-B6EAE095-7DC9-462D-880B-CF420F65AE96

P2093

Q38795605-43AC1B86-7785-46BC-A738-90D0BA433A8F

Q38795605-6C2B9804-82CC-4942-B8EB-867EE72F39AA

Q38795605-85FE3BAD-F866-4F91-8DAC-9EE70464FB9F

Q38795605-EB871C6D-C6FB-4244-AC22-1382C3F80FF4

P2860

Q38795605-06BC35FE-1211-41D3-AD97-DA41C239CADE

Q38795605-0DE70231-AEF6-4864-AA55-DD813C45F9A7

Q38795605-26900068-930B-41A8-BFDE-DB10C3C08D79

Q38795605-28421304-8EDD-4413-9B65-0A79EA95CDD2

Q38795605-3519075F-961B-435C-B296-CF65E60F7C34

Q38795605-46379A8C-409F-445E-ADA6-084D26099105

Q38795605-4CCEEA7A-4A26-40E5-B021-CBEE875C8929

Q38795605-55C38FCC-41CE-4FF9-AAC2-E6DFDF5F1BC1

Q38795605-561C5A10-34EA-487E-9875-FC1952892A71

Q38795605-5D8968B8-6A91-4A27-83C9-7D7AFF021360

P2888

Q38795605-AE435C26-BEF6-4B23-A9DF-B49F1BE668FE

P304

Q38795605-C0BE4571-0050-493F-8BB5-E8AF72EA6343

P31

Q38795605-BAFBFB5B-96C4-4F05-B439-BEE60EC5807A

P356

Q38795605-05DDA459-FAF3-4926-B797-6C69BC80F3C6

P433

Q38795605-C35BF791-7343-4DF3-AAAC-CB2CDD5C5800

P478

Q38795605-3F204E31-3727-4B13-A8E9-D60FFDBCA7F8

P50

Q38795605-2100C437-F3B3-46B1-92EE-DD49925DA0E0

P577

Q38795605-3BB2BE6D-7173-4837-A23D-5AECE3BB1554

P5875

Q38795605-9967E784-B739-425B-9A75-347B8E130BFA

P6179

Q38795605-5970392D-A9AA-4475-BC1A-EE4C492DBC10

P698

Q38795605-7CE665BE-DA43-4FF6-BB31-7A0B0064F8A7

P932

Q38795605-0BDFAC4F-8250-47A7-BDC0-E93D06DBD912

P356

P1433

Mucosal Immunology

P1476

IL-27, targeting antigen-prese ...... rentiation and colitis in mice

@en

P2093

A Visperas

http://www.w3.org/2001/XMLSchema#string

B Min

http://www.w3.org/2001/XMLSchema#string

K Bulek

http://www.w3.org/2001/XMLSchema#string

X Li

http://www.w3.org/2001/XMLSchema#string

P2860

WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27

Common variants at five new loci associated with early-onset inflammatory bowel disease

Differentiation of effector CD4 T cell populations (*)

Inflammatory bowel disease

IL-27 regulates homeostasis of the intestinal CD4+ effector T cell pool and limits intestinal inflammation in a murine model of colitis.

IL-27 promotes T cell-dependent colitis through multiple mechanisms.

Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells.

A role for IL-27p28 as an antagonist of gp130-mediated signaling.

The cytokines interleukin 27 and interferon-γ promote distinct Treg cell populations required to limit infection-induced pathology.

T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/Signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon gamma expression by T cells

P2888

P304

625-633

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MI.2013.82

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257838618

http://www.w3.org/2001/XMLSchema#string

P6179

1033989665

http://www.w3.org/2001/XMLSchema#string

P698

24129161

http://www.w3.org/2001/XMLSchema#string

P932

3989480

http://www.w3.org/2001/XMLSchema#string